Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Impax Asset Management Group plc

Impax Asset Management Group plc raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 43.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,167 shares of the medical equipment provider’s stock after purchasing an additional 1,577 shares during the period. Impax Asset Management Group plc’s holdings in Intuitive Surgical were worth $2,538,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Oak Harbor Wealth Partners LLC grew its holdings in shares of Intuitive Surgical by 4.0% during the third quarter. Oak Harbor Wealth Partners LLC now owns 833 shares of the medical equipment provider’s stock valued at $409,000 after purchasing an additional 32 shares during the last quarter. Sycomore Asset Management increased its position in Intuitive Surgical by 63.0% in the third quarter. Sycomore Asset Management now owns 14,866 shares of the medical equipment provider’s stock worth $7,230,000 after buying an additional 5,746 shares during the period. Tokio Marine Asset Management Co. Ltd. lifted its stake in Intuitive Surgical by 6.7% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 10,021 shares of the medical equipment provider’s stock valued at $4,923,000 after buying an additional 632 shares during the last quarter. Black Swift Group LLC acquired a new position in shares of Intuitive Surgical during the third quarter valued at $3,242,000. Finally, Metis Global Partners LLC grew its position in shares of Intuitive Surgical by 3.2% during the third quarter. Metis Global Partners LLC now owns 16,127 shares of the medical equipment provider’s stock worth $7,923,000 after acquiring an additional 505 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG stock opened at $527.61 on Friday. The firm has a market capitalization of $187.92 billion, a P/E ratio of 84.82, a P/E/G ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $295.02 and a 52-week high of $544.38. The company’s 50 day simple moving average is $499.29 and its 200-day simple moving average is $457.89.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent analyst reports. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Robert W. Baird upped their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Leerink Partners raised their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares in the company, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 91,178 shares of company stock valued at $45,897,071 in the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.